MedPath

Intensive Neurorehabilitation and Stimulation in Chronic Stroke Patients

Not Applicable
Conditions
Chronic Stroke
Interventions
Device: Contralesional stimulation
Device: Ipsilesional stimulation
Registration Number
NCT03947645
Lead Sponsor
University Hospital Tuebingen
Brief Summary

Chronic stroke patients (\> 6 months) with severe motor impairment of the upper extremity will be enrolled in this single-centre, randomized controlled clinical trial (RCT). All patients will take part in two blocks of high-intense motor training with concurrent neuromuscular stimulation of the paretic upper extremity. In a randomized, cross-over block design, patients will receive transcranial stimulation of either the ipsi- or contralesional hemisphere.

Detailed Description

Chronic stroke patients (\> 6 months) with severe motor impairment of the upper extremity and non-proportional recovery will be enrolled in this single-centre, randomized controlled clinical trial (RCT). All patients will take part in two blocks of high-intense motor training with concurrent neuromuscular stimulation of the paretic upper extremity. In a randomized, cross-over block design, patients will receive transcranial stimulation of either the ipsi- or contralesional hemisphere.

The primary outcome measure is the Fugl-Meyer Assessment for upper extremity (FM-UE), acquired at baseline, after the intervention period, and at 3 months follow-up. Secondary outcome measures consist of further clinical parameters and biomarkers of corticospinal connectivity.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Written informed consent
  • Chronic stage of stroke (> 6 months)
  • No active finger extension/hand opening of the paretic side
Exclusion Criteria
  • Pregnancy
  • Epilepsy
  • Metal implants
  • Pacemaker

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Contralesional stimulationContralesional stimulationContralesional stimulation
Ipsilesional stimulationIpsilesional stimulationIpsilesional stimulation
Primary Outcome Measures
NameTimeMethod
Fugl-Meyer Assessment (Upper Extremity)change from baseline to both directly after intervention and 3 months after
Secondary Outcome Measures
NameTimeMethod
Modified Ashworth Scale (MAS)change from baseline to both directly after intervention and 3 months after

Spasticity in different body parts. Scale ranges from 0 (no spasticity) to 4 (rigid).

National Institute of Stroke Scale (NIHSS)baseline

Assessment of severity of stroke and neurological deficits. Scale ranges from 0 (normal) to 2, 3 or 4 (depending on the item).

Stroke Impact Scalechange from baseline to both directly after intervention and 3 months after

Questionnaire on subjective impact of stroke on daily living and health status. Scale ranges from 1 (most negative answer) to 5 (most positive answer).

Hospital Anxiety and Depression Scalechange from baseline to both directly after intervention and 3 months after

Questionnaire on anxiety and depression. Scale ranges from 0 (most positive answer) to 3 (most negative answer).

Neurological Fatigue Indexchange from baseline to both directly after intervention and 3 months after

Questionnaire on fatigue in the last two weeks. Scale ranges from no agreement at all, no agreement, agreement to some extent to full agreement.

Credibility/Expectancy Questionnairechange from baseline to both directly after intervention and 3 months after

Questionnaire to evaluate expectancies on current program. Scale rangs from 0 (most negative) to 9 (most positive).

Action Research Arm Test (ARAT)change from baseline to both directly after intervention and 3 months after

Motor Impairment of the upper extremity. Several objects in different sizes and weights should be moved by patients.

10m walking testchange from baseline to both directly after intervention and 3 months after

Assessment of motor impairment of the lower extremity.

CAHAI-13change from baseline to both directly after intervention and 3 months after

Test on activities of daily living. Patients should perform several tasks and are scored from 1 (total assist) to 7 (complete independence).

NEO-Fünf-Faktoren Inventarbaseline

Personality questionnaire with 60 statements that patients should rate ranging from strong disagreement, disagreement, neutral, agreement to strong agreement.

Berlin Social Support Scalechange from baseline to both directly after intervention and 3 months after

Questionnaire to evaluate social support. Patients should rate different questions regarding their most important attachment figure ranging from no agreement at all, no agreement, agreement to some extent to full agreement.

Barthel Indexchange from baseline to both directly after intervention and 3 months after

Questionnaire on extent to which patients can perform activities of daily living on their own. Patients can reach 0 (cannot perform any task) to a maximum of 100 points (can do everything on their own).

Arm-Achange from baseline to both directly after intervention and 3 months after

Questionnaire on capability to care for the paretic arm in different situations of daily living. Scale ranges from 0 (no problems) to 4 (impossible to do).

Fugl-Meyer Assessment (Lower Extremity)change from baseline to both directly after intervention and 3 months after

Assessment of motor impairment of the lower extremity.

Modified Rankin Scale (mRS)change from baseline to both directly after intervention and 3 months after

Degree of disability after stroke on a scale from 0 (no symptoms) to 6 (dead).

EQ-5Dchange from baseline to both directly after intervention and 3 months after

Questionnaire on subjective health status. Patients should rate their health status for that day in different tasks of daily living on a scale from no problems, minor problems, moderate problems, big problems to not possible at all.

Situational Motivation Scalechange from baseline to both directly after intervention and 3 months after

Questionnaire on motivation to participate in training. Scale ranges from 0 (not correct at all) to 6 (strongly agree).

Trial Locations

Locations (1)

University Hospital Tübingen

🇩🇪

Tübingen, Baden-Württemberg, Germany

© Copyright 2025. All Rights Reserved by MedPath